<DOC>
	<DOCNO>NCT01144728</DOCNO>
	<brief_summary>Primary Objective : - To describe condition initiation titration Amaryl M , accord previous treatment : - initial dose - titration scheme - efficacy 4 month assess HbA1C - tolerability ( number severity hypoglycaemia ) Secondary Objective : - Fasting Plasma Glucose - Weight evolution</brief_summary>
	<brief_title>Initiation Titration Amaryl</brief_title>
	<detailed_description />
	<mesh_term>Diabetes Mellitus</mesh_term>
	<mesh_term>Diabetes Mellitus , Type 2</mesh_term>
	<mesh_term>Glimepiride</mesh_term>
	<mesh_term>Metformin</mesh_term>
	<criteria>Inclusion criterion : Patients Type 2 diabetes treat stable dose ( dose ) : sulfonylurea monotherapy metformin monotherapy free combination glimepiride metformin stable dose ( dose ) Body Mass Index ( BMI ) 20 40 kg/m2 HbA1c superior egal 7.5 % FPG superior egal 7 mmol/l Exclusion criterion : Secondary insulindependant diabetes Any severe chronic disease ( hepatic , renal impairment ) History major cardiovascular event last 6 month Acute condition potential alter renal function : dehydratation , severe infection , shock , IV administration iodinate contrast agent Allergy sulfonylurea , metformin Drug alcohol abuse Pregnancy , lactation The information intend contain consideration relevant patient 's potential participation clinical trial .</criteria>
	<gender>All</gender>
	<minimum_age>35 Years</minimum_age>
	<maximum_age>75 Years</maximum_age>
	<verification_date>January 2011</verification_date>
</DOC>